Airborne, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Airborne, Inc. - overview
Location
Minneapolis, MN, US
Primary Industry
Food
About
Airborne, Inc. specializes in the development and marketing of health supplements aimed at enhancing immune system support, particularly during cold and flu seasons, with a focus on convenience and effectiveness for consumers. Airborne, Inc. is a health supplement company based in Minneapolis, US.
The company provides immune support products, undergoing a significant change when Schiff Nutrition acquired it for USD 150 mn in March 2012. The company was founded by Emmanuel Trenche, Hugo Tabares, Marvin Jacobs, and Rina Desai, while Arno Mourik currently serves as CEO. Airborne offers a variety of immune support supplements under its brand, including gummies, effervescents, and chewables designed for both adults and children. These products are formulated to support immune health, targeting health-conscious consumers, especially families.
Airborne's products, marketed in the US and select international markets, leverage scientifically-backed formulations to meet the growing demand for effective dietary supplements. In the most recent fiscal year of 2011, Airborne generated a revenue of USD 70. 00 mn through retail and direct-to-consumer sales channels, focusing on partnerships with major retailers and e-commerce platforms. The company's revenue model is supported by consumer loyalty programs like Schiff Rewards, enhancing repeat purchases and fostering strong customer relationships.
Airborne plans to utilize recent funding from the acquisition to invest in new product development and expand its market reach. There are upcoming launches of innovative immune support products targeting health-conscious consumers, planned for rollout within the next year. Additionally, the company is exploring expansion into new geographic regions, aiming to enter emerging markets and increase its international presence.
Current Investors
TPG Biotech, Schiff Nutrition
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements
Website
www.airbornehealth.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Airborne, Inc. - financials
| Fiscal Year Ended | Jan 01, 2011 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Airborne, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Airborne, Inc. | - | ||||||||
| Buyout | Completed | Airborne, Inc. | - |
Displaying 1 - 2 of 2
Airborne, Inc. - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.